Her primary scientific interests are in Amyotrophic lateral sclerosis, Psychiatry, Verbal fluency test, Neuroscience and Cognition. Her Amyotrophic lateral sclerosis research incorporates themes from Audiology, Neuroimaging and Frontotemporal dementia. Her Psychiatry study which covers Clinical psychology that intersects with Bipolar disorder and Clinical trial.
The various areas that Laura H. Goldstein examines in her Verbal fluency test study include Cognitive psychology, Executive dysfunction, Functional imaging, Functional magnetic resonance imaging and Executive functions. Her research in Cognition intersects with topics in Dementia and Disease. Her studies in Epilepsy integrate themes in fields like Neurology, Cognitive therapy and Neuropsychiatry.
Laura H. Goldstein spends much of her time researching Epilepsy, Psychiatry, Clinical psychology, Cognition and Amyotrophic lateral sclerosis. Her Epilepsy research is multidisciplinary, incorporating elements of Psychological intervention, Neurology and Randomized controlled trial. Her Psychiatry study frequently links to adjacent areas such as Motor neurone disease.
Her Clinical psychology research incorporates elements of Cognitive behavioral therapy, Anxiety and Social support. Her Cognition research includes themes of Developmental psychology, Disease and Physical medicine and rehabilitation. Her Amyotrophic lateral sclerosis research is multidisciplinary, incorporating perspectives in Audiology, Frontotemporal dementia, Executive dysfunction and Neuroimaging, Neuroscience.
Laura H. Goldstein mainly investigates Clinical psychology, Epilepsy, Randomized controlled trial, Anxiety and Conversion disorder. Her Clinical psychology research is multidisciplinary, relying on both Cognitive behavioral therapy, Dissociation and Cognition. Her biological study spans a wide range of topics, including Functional ability and Physical medicine and rehabilitation.
Epilepsy is a subfield of Psychiatry that Laura H. Goldstein investigates. Her Randomized controlled trial study combines topics from a wide range of disciplines, such as Physical therapy and Psychoeducation. Her work carried out in the field of Conversion disorder brings together such families of science as Clinical trial and Psychogenic Seizure, Psychogenic disease.
The scientist’s investigation covers issues in Conversion disorder, Epilepsy, Anxiety, Physical therapy and Randomized controlled trial. Laura H. Goldstein interconnects Valence, Cognition and Psychogenic Seizure, Psychogenic disease in the investigation of issues within Conversion disorder. The study incorporates disciplines such as Clinical trial, Etiology and Clinical psychology in addition to Psychogenic disease.
Laura H. Goldstein interconnects Psychosocial and Psychological intervention in the investigation of issues within Epilepsy. Psychosocial is a subfield of Psychiatry that she tackles. Laura H. Goldstein has included themes like Ictal, Cognitive skill, Arousal and Audiology in her Anxiety study.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Minimum requirements for the diagnosis of psychogenic nonepileptic seizures: a staged approach: a report from the International League Against Epilepsy Nonepileptic Seizures Task Force.
W. Curt LaFrance;W. Curt LaFrance;Gus A. Baker;Rod Duncan;Laura H. Goldstein.
Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosis
Michael J. Strong;Gloria M. Grace;Morris Freedman;Cathy Lomen-Hoerth.
Amyotrophic Lateral Sclerosis (2009)
Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria
Michael J. Strong;Sharon Abrahams;Laura H. Goldstein;Susan Woolley.
Amyotrophic Lateral Sclerosis (2017)
Cognitive-behavioral therapy for psychogenic nonepileptic seizures: A pilot RCT
Laura Goldstein;Trudie Chalder;C Chigwedere;Mizanur Khondoker.
Verbal fluency and executive dysfunction in amyotrophic lateral sclerosis (ALS)
S Abrahams;Peter Leigh;A Harvey;G N Vythelingum.
Changes in cognition and behaviour in amyotrophic lateral sclerosis: nature of impairment and implications for assessment
Laura H Goldstein;Sharon Abrahams.
Lancet Neurology (2013)
The physiology of coloured hearing A PET activation study of colour-word synaesthesia
E. Paulesu;J. Harrison;S. Baron-Cohen;J. D. G. Watson.
Current Concepts in Diagnosis and Treatment of Functional Neurological Disorders.
Alberto J. Espay;Selma Aybek;Alan Carson;Mark J. Edwards.
JAMA Neurology (2018)
Frontal lobe dysfunction in amyotrophic lateral sclerosis. A PET study
S. Abrahams;L. H. Goldstein;J. J. M. Kew;D. J. Brooks.
The management of motor neurone disease
PN Leigh;S Abrahams;A Al-Chalabi;MA Ampong.
Journal of Neurology, Neurosurgery, and Psychiatry (2003)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: